

Research Topics and Interests
- Mental health consequences of cardiac device therapy
- Mental Health in patients with cardiac arrythmia
- The application of subcutaneous defillibrators among various coronary diseases
- Interventional Therapy for cardiac arrythmia
Curriculum Vitae
since 2020
Associated Research Member, Clinical Psychology and Psychotherapy,
WWU Münstersince 02/2018
Assistant Doctor at Medical Department, Division of Cardiology II – Rhythmology, University Medical Center Münster, Director: Prof. Dr. med. Lars Eckardt2019-2021
Masters Degree Psychology (M.Sc.), Health and sports psychology, extra-occupational education, PFH Göttingen2014-2018
Experimental doctoral thesis at the Medical Department, Division of Nephrology and Internal Intensive Care Medicine, Charité Campus Virchow
„Vaskuläre Kalzifikation bei Patienten mit chronischer Nierenerkrankung“ (magna cum laude)
2014-2018
Bachelors Degree Psychology (B.Sc.), Distance Learning University Hagen2011-2017
Study of Human Medicine, Charité Medical-School Berlin2008-2009
Junior Student of Philosophy, University of BielefeldPublications
Willy K, Reinke F, Bögeholz N, Ellermann C, Rath B, Köbe J, Eckardt L, Frommeyer G. The role of entirely subcutaneous ICDTM systems in patients with dilated cardiomyopathy. J Cardiol. 2019 Nov 16. pii: S0914-5087(19)30335-1. doi: 10.1016/j.jjcc.2019.10.005.Willy K, Reinke F, Bögeholz N, Ellermann C, Rath B, Leitz P, Köbe J, Eckardt L, Frommeyer G. Outcome differences and device performance of the subcutaneous ICD in patients with and without structural heart disease. Clin Res Cardiol. 2019 Oct 31. doi: 10.1007/s00392-019-01564-1.
Willy K, Reinke F, Bögeholz N, Köbe J, Eckardt L, Frommeyer G. Performance of the entirely subcuteaneous ICD in borderline indications. Clin Res Cardiol. 2019 Oct 4. doi: 10.1007/s00392-019-01558-z.
Willy K, Dechering DG, Wasmer K, Köbe J, Bögeholz N, Ellermann C, Leitz P, Reinke F, Frommeyer G, Eckardt L. Outcome of catheter ablation of supraventricular tachycardias in patients with cardiac sarcoidosis. Clin Cardiol. 2019 Sep 3. doi: 10.1002/clc.23263.
Willy K, Reinke F, Bögeholz N, Köbe J, Eckardt L, Frommeyer G. The entirely subcutaneous ICDTM system in patients with congenital heart disease: experience from a large single-centre analysis.
Europace. 2019 Oct 1;21(10):1537-1542. doi: 10.1093/europace/euz190.Willy K, Bettin M, Reinke F, Bögeholz N, Ellermann C, Rath B, Leitz P, Köbe J, Eckardt L, Frommeyer G. Feasibility of entirely subcutaneous ICD™ systems in patients with coronary artery disease. Clin Res Cardiol. 2019 Mar 21. doi: 10.1007/s00392-019-01455-5.
Bögeholz N, Willy K, Niehues P, Rath B, Dechering DG, Frommeyer G, Kochhäuser S, Löher A, Köbe J, Reinke F, Eckardt L. Spotlight on S-ICD™ therapy: 10 years of clinical experience and innovation.
Europace. 2019 Mar 18. pii: euz029. doi: 10.1093/europace/euz029.Engelke HH, Willy K, Eckardt L Akut lebensbedrohliche Herzrhythmusstörungen. Intensivmedizin up2date 2019; 15(04): 399-410. doi: 10.1055/a-0759-7033
Willy K, Dechering DG, Eckard L. Therapie von Vorhofflimmern bei Herzinsuffizienz – sind die Leitlinien noch aktuell? Aktuelle Kardiologie 2018; 7(06): 476-480. doi: 10.1055/a-0681-6521
Willy K, Girndt M, Voelkl J, Fiedler R, Martus P, Storr M, Schindler R, Zickler D. Expanded Hemodialysis Therapy of Chronic Hemodialysis Patients Prevents Calcification and Apoptosis of VSMC In Vitro. Blood Purif 2018;45:131–138. doi:10.1159/000484925.
Zickler D, Luecht C, Willy K, Chen L, Witowski J, Girndt M, Fiedler R, Storr M, Kamhieh-Milz J, Schoon J, Geissler S, Ringdén O, Schindler R, Moll G, Dragun D, Catar R. TNF-alpha in uraemic serum promotes osteoblastic transformation and calcification of vascular smooth muscle cells via ERK and AP-1/c-FOS-mediated induction of IL-6 expression. Nephrol Dial Transplant. 2017 Dec 8. doi: 10.1093/ndt/gfx316.
Trojanowicz B, Ulrich C, Fiedler R, Martus P, Storr M, Boehler T, Werner K, Hulko M, Zickler D, Willy K, Schindler R, Girndt M. Modulation of leucocytic angiotensin-converting enzymes expression in patients maintained on high-permeable haemodialysis. Nephrol Dial Transplant. 2017 Jul 19. doi:10.1093/ndt/gfx206.
Willy K, Hulko M, Storr M, Speidel R, Gauss J, Schindler R, Zickler D. In Vitro Dialysis of Cytokine Rich Plasma With High and Medium Cut-Off Membranes Reduces Its Procalcific Activity, Artif Organs. 2017 May 19. doi:10.1111/aor.12884.
Zickler D, Schindler R, Willy K, Martus P, Pawlak M, Storr M, Hulko M, Boehler T, Glomb MA, Liehr K, Henning C, Templin M, Trojanowicz B, Ulrich C, Werner K, Fiedler R, Girndt M. Medium Cut-Off (MCO) Membranes Reduce Inflammation in Chronic Dialysis Patients – A Randomized Controlled Clinical Trial, PLoS One. 2017 Jan13; 12(1). doi:10/1371/journal.pone.0169024.
Trojanowicz B, Ulrich C, Fiedler R, Storr M, Boehler T, Martus P, Pawlak M, Glomb MA, Henning C, Templin M, Werner K, Zickler D, Willy K, Schindler R, Girndt M. Impact of serum and dialysates from chronic hemodialysis patients maintained on high cut-off membranes on inflammation profile in human THP-1 monocytes. Hemodial Int. 2016 Sep 26. doi:10.1111/hdi.12494.
Zickler D, Willy K, Girndt M, Fiedler R, Martus P, Storr M, Schindler R. High cut-off dialysis in chronic haemodialysis patients reduces serum procalcific activity. Nephrol Dial Transplant. 2016, Oct; 31(10):1706-12. doi:10.1093/ndt/gfw293